SFI
BNR

Susquehanna Fundamental Investments’s Burning Rock Biotech BNR Stock Holding History

Susquehanna Fundamental Investments’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$221K Sell
2,382
-143
-6% -$12.4K ﹤0.01% 1335
2021
Q4 		$241K Sell
2,525
-737
-23% -$101K 0.01% 1182
2021
Q3 		$583K Buy
+3,262
New +$725K 0.01% 1126

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna Fundamental Investments's BNR Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Burning Rock Biotech (BNR) stake by 5.7% in Q1 2022, selling an estimated $12.4K and leaving 2,382 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

Susquehanna Fundamental Investments first reported a position in BNR in Q3 2021 and has held it in 3 quarters since. The position peaked at $583K in Q3 2021. 46 funds tracked by Wall St. Rank hold BNR as of Q1 2022.

  • Susquehanna Fundamental Investments held 2,382 shares of Burning Rock Biotech worth $221K as of Q1 2022.
  • Susquehanna Fundamental Investments sold 143 Burning Rock Biotech shares in Q1 2022, an estimated $12.4K.
  • Burning Rock Biotech made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1335 holding.
  • Susquehanna Fundamental Investments first reported a position in Burning Rock Biotech in Q3 2021 and has held it in 3 quarters since.
  • Susquehanna Fundamental Investments's Burning Rock Biotech position peaked at $583K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.